Skip to main content
. Author manuscript; available in PMC: 2009 Aug 21.
Published in final edited form as: Clin Exp Metastasis. 2007 Dec 11;25(3):201–211. doi: 10.1007/s10585-007-9133-3

Fig. 2. CTCE-9908 decreases the growth rate of K7M2 cells in vitro.

Fig. 2

(a) K7M2 cells treated with CTCE-9908 have a decrease in growth rate as determined by optical density, shown on the Y-axis, following treatment with MTT. Control cells have a doubling time of 20 h whereas CTCE-9908 treated cells have a doubling time of 27 h. (b) Microscopic visualization of treated and untreated cells at 72 h show no phenotypic differences. This finding, and the fact that cells began their growth divergence after 25 h, suggests that the decrease in proliferative capability is not due to cytotoxicity of the compound